Bio-Rad Laboratories (BIO.B) News Today $339.75 +2.68 (+0.80%) (As of 12/17/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Bio-Rad Laboratories (NYSE:BIO.B) Trading Up 2.3% - Should You Buy?Bio-Rad Laboratories (NYSE:BIO.B) Stock Price Up 2.3% - Should You Buy?December 17 at 12:34 AM | marketbeat.comBio-Rad’s Management to Host Investor Meetings at Citi's 2024 Global Healthcare ConferenceNovember 21, 2024 | finance.yahoo.comBio-Rad Laboratories (NYSE:BIO.B) Reaches New 52-Week High - Here's What HappenedBio-Rad Laboratories (NYSE:BIO.B) Reaches New 52-Week High - Time to Buy?November 8, 2024 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Just Released Its Third-Quarter Results And Analysts Are Updating Their EstimatesNovember 3, 2024 | uk.finance.yahoo.comWells Fargo Remains a Hold on Bio-Rad Laboratories (BIO)November 2, 2024 | markets.businessinsider.comBio-Rad Laboratories Reports Q3 2024 Earnings GrowthNovember 1, 2024 | markets.businessinsider.comPlatforma.bio by MiLaboratories is making waves in drug discoveryOctober 18, 2024 | venturebeat.comPCR Technologies Market to Hit USD 21.89 Billion by 2030 with 7.7% CAGR | MarketsandMarketsOctober 12, 2024 | finanznachrichten.deBio-Rad Laboratories Stock: Is BIO Underperforming the Healthcare Sector?September 30, 2024 | msn.comCS Genetics Appoints Bill Colston, PhD, as Chief Executive OfficerSeptember 25, 2024 | finance.yahoo.comBio-Rad Laboratories (NYSE:BIO.B) Trading Down 0%Bio-Rad Laboratories (NYSE:BIO.B) Stock Price Down 0%September 12, 2024 | marketbeat.comBio-Rad Appoints Jon DiVincenzo President, Chief Operating OfficerAugust 20, 2024 | finance.yahoo.comBio-Rad Laboratories, Inc. (NYSE:BIO) Q2 2024 Earnings Call TranscriptAugust 3, 2024 | msn.comBio-Rad Laboratories (NYSE:BIO.B) Issues Quarterly Earnings ResultsBio-Rad Laboratories (NYSE:BIO.B - Get Free Report) issued its earnings results on Thursday. The company reported $3.11 earnings per share (EPS) for the quarter. Bio-Rad Laboratories had a positive return on equity of 3.59% and a negative net margin of 12.37%. The business had revenue of $638.48 million during the quarter.August 2, 2024 | marketbeat.comBio-Rad Laboratories (NYSE:BIO.B) Shares Gap Up to $294.23Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap Up to $294.23August 2, 2024 | marketbeat.comThe Future is Wearable: Advancing Human Health Through Portable SpectroscopyJuly 20, 2024 | msn.comBio-Rad Laboratories (NYSE:BIO.B) Shares Gap Up to $283.45Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap Up to $283.45July 19, 2024 | marketbeat.comBio-Rad: Economics Unsupportive With Capital Valued 70 Cents On The DollarJuly 14, 2024 | seekingalpha.comBio-Rad Laboratories (NYSE:BIO.B) Reaches New 12-Month Low at $268.24Bio-Rad Laboratories (NYSE:BIO.B) Hits New 1-Year Low at $268.24July 2, 2024 | marketbeat.comBio-Rad Laboratories (NYSE:BIO.B) Stock Price Passes Below 200 Day Moving Average of $311.79Bio-Rad Laboratories (NYSE:BIO.B) Share Price Crosses Below Two Hundred Day Moving Average of $311.79June 14, 2024 | marketbeat.comBio-Rad Laboratories (NYSE:BIO.B) Shares Up 3%Bio-Rad Laboratories (NYSE:BIO.B) Stock Price Up 3%June 4, 2024 | marketbeat.comBio-Rad Laboratories (NYSE:BIO.B) Stock Price Down 17.3%Bio-Rad Laboratories (NYSE:BIO.B) Stock Price Down 17.3%May 13, 2024 | marketbeat.comBio-Rad Laboratories (NYSE:BIO.B) Shares Gap Down to $338.55Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap Down to $338.55May 8, 2024 | marketbeat.comAnalysts Are Bullish on These Healthcare Stocks: Bio-Rad Laboratories (BIO), Caribou Biosciences (CRBU)May 8, 2024 | markets.businessinsider.comThe Analyst Landscape: 4 Takes On Bio-Rad LaboratoriesMay 8, 2024 | markets.businessinsider.comBio-Rad launches three StarBright Red Dyes and expands range of antibody markers conjugated to StarBright Violet Dyes to enhance immunology researchMay 1, 2024 | msn.comBio-Rad Laboratories (NYSE:BIO.B) Sets New 12-Month Low at $268.80Bio-Rad Laboratories (NYSE:BIO.B) Sets New 1-Year Low at $268.80April 30, 2024 | marketbeat.comBio-Rad Laboratories (BIO.B) to Release Earnings on TuesdayBio-Rad Laboratories (NYSE:BIO.B) will be releasing earnings after the market closes on Tuesday, May 7, Zacks reports.April 30, 2024 | marketbeat.comOncology Market Expected to Grow at 9.6% CAGR, Reaching USD 533.2 Bn by 2032 | DMRApril 25, 2024 | finance.yahoo.comLyme Disease Diagnostic Market Research Report 2024: Global Trends, Forecasts and Competitive Analysis to 2030April 21, 2024 | finance.yahoo.comBio-Rad’s Chief Operating Officer Andrew Last to RetireApril 10, 2024 | businesswire.comBio-Rad Laboratories (NYSE:BIO.B) Shares Down 1.6% Bio-Rad Laboratories (NYSE:BIO.B) Trading Down 1.6%April 9, 2024 | marketbeat.comUnlocking Precision in Diagnosis: The Rise of Molecular Point-of-Care SolutionsApril 1, 2024 | finance.yahoo.comGlobal Glucometer Market Projected to Reach $30.5 Billion by 2030, With a CAGR of 8.9%April 1, 2024 | uk.finance.yahoo.comBio-Rad launches validated antibodies for rare cell and circulating tumor cell enumerationMarch 26, 2024 | msn.comBIO Apr 2024 350.000 putMarch 17, 2024 | finance.yahoo.comBIO Apr 2024 330.000 callMarch 16, 2024 | finance.yahoo.comInsightAce Analytics Pvt. Ltd.: Combo IVD Market worth $920.9 Mn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.March 14, 2024 | finanznachrichten.deBio-Rad launches vericheck ddPCR replication competent lentivirus and replication competent AAV kits for cell and gene therapy productionFebruary 27, 2024 | msn.comBio-Rad Laboratories is about to announce earnings — here's what Wall Street expectsFebruary 14, 2024 | markets.businessinsider.comRecombinant Proteins Market Worth $3.2 Billion | MarketsandMarkets™.February 6, 2024 | finance.yahoo.comMeta's fake videos should be labelled, says boardFebruary 5, 2024 | nz.finance.yahoo.comRBC Capital Remains a Buy on Bio-Rad Laboratories (BIO)January 27, 2024 | markets.businessinsider.comBe Bio Announces New Preclinical Data Demonstrating its Novel Engineered B Cell Medicine (BCM), BE-101, Produces Active and Sustained Levels of Factor IX for the Treatment of ...December 10, 2023 | businesswire.comBio-Rad (BIO) Hurt by Macroeconomic Woes, Margin PressureNovember 14, 2023 | msn.comBio-Rad Laboratories (BIO) Q3 Earnings and Revenues Miss EstimatesOctober 26, 2023 | finance.yahoo.comBio-Rad Labs cuts 2023 revenue growth forecast as biotechs cut spendingOctober 26, 2023 | reuters.comBio-Rad Laboratories Inc. Class BSeptember 13, 2023 | thestreet.comBio-Rad and QIAGEN announce patent settlement and cross-licensing agreementJuly 26, 2023 | technews.tmcnet.comBio-Rad Laboratories (BIO) Dips More Than Broader Markets: What You Should KnowJune 16, 2023 | msn.com Get Bio-Rad Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for BIO.B and its competitors with MarketBeat's FREE daily newsletter. Email Address Do this Before Elon’s Reveal on January 22nd (Ad)Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen. I urge you to watch this video now. BIO.B Media Mentions By Week BIO.B Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIO.B News Sentiment▼0.000.71▲Average Medical News Sentiment BIO.B News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIO.B Articles This Week▼10▲BIO.B Articles Average Week Get Bio-Rad Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for BIO.B and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies KEYS News Today FTV News Today VLTO News Today TER News Today AVTR News Today RVTY News Today VNT News Today NVMI News Today ST News Today MIR News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BIO.B) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Rad Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Rad Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BIO.B Stock Alerts